Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 9, 2016

Total Value: $87.13M (100.0% shares, 0.0% debt)

Holdings (26)

LOXO ONCOLOGY INC 7.8%
Value $6.835M Shares 250,000 Est. Cost $28.45 Unrealized
EPIZYME INC 7.6%
Value $6.605M Shares 545,000 Est. Cost $14.50 Unrealized
FOUNDATION MEDICINE INC 7.0%
Value $6.09M Shares 335,000 Est. Cost $19.17 Unrealized
SAGE THERAPEUTICS INC 7.0%
Value $6.059M Shares 189,000 Est. Cost $51.92 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 6.9%
Value $6.009M Shares 148,000 Est. Cost $57.64 Unrealized -25.8%
BLUEPRINT MEDICINES CORP 6.7%
Value $5.799M Shares 321,300 Est. Cost $26.34 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 6.5%
Value $5.649M Shares 90,000 Est. Cost $83.97 Unrealized -20.8%
BLUEBIRD BIO INC 5.9%
Value $5.1M Shares 120,000 Est. Cost $60.60 Unrealized
MYOKARDIA INC 5.8%
Value $5.091M Shares 475,350 Est. Cost $14.07 Unrealized
SPARK THERAPEUTICS INC 5.8%
Value $5.017M Shares 170,000 Est. Cost $42.99 Unrealized
CTMX CYTOMX THERAPEUTICS INC 4.8%
Value $4.141M Shares 321,023 Est. Cost $15.82 Unrealized -12.2%
KITE PHARMA INC 4.0%
Value $3.443M Shares 75,000 Est. Cost $52.20 Unrealized
VYGR VOYAGER THERAPEUTICS INC 3.4%
Value $2.963M Shares 339,362 Est. Cost $17.92 Unrealized
EDIT EDITAS MEDICINE INC 3.4%
Value $2.952M Shares 85,470 Est. Cost $26.29 Unrealized 0.0%
DXCM DEXCOM INC 3.1%
Value $2.716M Shares 40,000 Est. Cost $18.45 Unrealized -9.5%
XBI SPDR SERIES TRUST 3.0%
Value $2.583M Shares 50,000 Est. Cost Unrealized
AVEXIS INC 2.0%
Value $1.716M Shares 63,000 Est. Cost $27.24 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.9%
Value $1.665M Shares 105,000 Est. Cost $26.05 Unrealized
GENOMIC HEALTH INC 1.6%
Value $1.362M Shares 55,000 Est. Cost $35.20 Unrealized
BMY BRISTOL MYERS SQUIBB CO 1.5%
Value $1.341M Shares 21,000 Est. Cost $46.69 Unrealized -4.0%
BIIB BIOGEN INC 1.5%
Value $1.302M Shares 5,000 Est. Cost $287.35 Unrealized -8.1%
ONC BEIGENE LTD 1.1%
Value $953K Shares 32,500 Est. Cost $29.32 Unrealized
IGNYTA INC 0.9%
Value $745K Shares 110,000 Est. Cost $6.77 Unrealized
EXAS EXACT SCIENCES CORP 0.5%
Value $404K Shares 60,000 Est. Cost $6.40 Unrealized 0.0%
MEDIDATA SOLUTIONS INC 0.4%
Value $387K Shares 10,000 Est. Cost $49.30 Unrealized
OXFORD IMMUNOTEC GLOBAL PLC 0.2%
Value $198K Shares 20,000 Est. Cost $11.51 Unrealized